Arcellx
Tiezheng (Kevin) Li is a Senior Scientist at Arcellx, with previous experience at Jecho Laboratories, Inc. working in Analytical Development. Prior to that, Tiezheng (Kevin) Li was a Postdoctoral Research Fellow at the University of Maryland College Park, specializing in therapeutic IgG antibody glycoengineering. Tiezheng (Kevin) Li earned a Ph.D. in Biochemistry and Molecular Biology from Marquette University, conducting research in bacterial lipopolysaccharide O-antigen biosynthesis.
This person is not in the org chart
Arcellx
2 followers
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.